Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)
China
· Delayed Price · Currency is CNY 8.19
-0.25 (-2.96%)
Apr 25, 2025, 2:45 PM CST
Jiangsu Yahong Meditech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Operating Revenue | 201.56 | 11.52 | 0.03 | 0 | - | Upgrade
|
| Other Revenue | - | 2.23 | - | - | - | Upgrade
|
| Revenue | 201.56 | 13.75 | 0.03 | 0 | - | Upgrade
|
| Revenue Growth (YoY) | 1365.55% | 52604.89% | 470.51% | - | - | Upgrade
|
| Cost of Revenue | 49.3 | 2.93 | 1.83 | 1.19 | 0.2 | Upgrade
|
| Gross Profit | 152.26 | 10.83 | -1.81 | -1.19 | -0.2 | Upgrade
|
| Selling, General & Admin | 262.75 | 117.55 | 88.29 | 63.86 | 78.45 | Upgrade
|
| Research & Development | 311.92 | 364.59 | 243.89 | 190.74 | 172.03 | Upgrade
|
| Other Operating Expenses | -3.38 | -0.31 | 0.27 | 0.03 | 0.18 | Upgrade
|
| Operating Expenses | 571.29 | 482.29 | 332.46 | 254.64 | 250.66 | Upgrade
|
| Operating Income | -419.02 | -471.47 | -334.27 | -255.82 | -250.87 | Upgrade
|
| Interest Expense | - | -2.97 | -0.77 | -0.48 | -0.05 | Upgrade
|
| Interest & Investment Income | 14.73 | 48.02 | 26.64 | 14.44 | 2.95 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.79 | 9.84 | -2.03 | -1.97 | Upgrade
|
| Other Non Operating Income (Expenses) | 8.74 | -0.76 | -0.16 | -0.36 | -0.55 | Upgrade
|
| EBT Excluding Unusual Items | -395.55 | -427.96 | -298.71 | -244.25 | -250.48 | Upgrade
|
| Gain (Loss) on Sale of Investments | 9.72 | 19.58 | 47.53 | 4.1 | 1.13 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.05 | - | - | -0.02 | - | Upgrade
|
| Asset Writedown | -1.01 | -0.03 | -0.01 | - | - | Upgrade
|
| Other Unusual Items | - | 6.9 | 5.93 | 5.42 | 2.09 | Upgrade
|
| Pretax Income | -386.8 | -401.5 | -245.27 | -234.75 | -247.27 | Upgrade
|
| Income Tax Expense | -0.8 | -0.67 | 1.28 | 0.19 | - | Upgrade
|
| Earnings From Continuing Operations | -386 | -400.83 | -246.55 | -234.95 | -247.27 | Upgrade
|
| Minority Interest in Earnings | 1.94 | 0.4 | - | - | - | Upgrade
|
| Net Income | -384.06 | -400.43 | -246.55 | -234.95 | -247.27 | Upgrade
|
| Net Income to Common | -384.06 | -400.43 | -246.55 | -234.95 | -247.27 | Upgrade
|
| Shares Outstanding (Basic) | 565 | 572 | 573 | 461 | 458 | Upgrade
|
| Shares Outstanding (Diluted) | 591 | 572 | 573 | 461 | 458 | Upgrade
|
| Shares Change (YoY) | 3.29% | -0.23% | 24.46% | 0.61% | - | Upgrade
|
| EPS (Basic) | -0.68 | -0.70 | -0.43 | -0.51 | -0.54 | Upgrade
|
| EPS (Diluted) | -0.68 | -0.70 | -0.43 | -0.51 | -0.54 | Upgrade
|
| Free Cash Flow | -430.74 | -499.82 | -268.57 | -213.92 | -140.25 | Upgrade
|
| Free Cash Flow Per Share | -0.73 | -0.87 | -0.47 | -0.46 | -0.31 | Upgrade
|
| Gross Margin | 75.54% | 78.72% | - | - | - | Upgrade
|
| Operating Margin | -207.89% | -3428.02% | -1280959.60% | -5592976.39% | - | Upgrade
|
| Profit Margin | -190.54% | -2911.54% | -944816.18% | -5136625.82% | - | Upgrade
|
| Free Cash Flow Margin | -213.70% | -3634.18% | -1029206.22% | -4676788.98% | - | Upgrade
|
| EBITDA | -403.62 | -463.69 | -330.15 | -253.25 | -249.5 | Upgrade
|
| EBITDA Margin | -200.25% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 15.4 | 7.78 | 4.11 | 2.57 | 1.36 | Upgrade
|
| EBIT | -419.02 | -471.47 | -334.27 | -255.82 | -250.87 | Upgrade
|
| EBIT Margin | -207.89% | - | - | - | - | Upgrade
|
| Revenue as Reported | - | 13.75 | 0.03 | 0 | - | Upgrade
|
| Advertising Expenses | - | 4.1 | 2.71 | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.